Training activity information

Details

Explore current clinical trials involving radiopharmaceuticals and reflect on the impact this will have on practice

Type

Observational training activity (OTA)

Evidence requirements

Evidence the observation or experience has been undertaken by the trainee.

Reflections on the observation or experience at two timepoints including contextualisation to the trainees own practice. E.g., for planned observations, a reflection before the observation and after, or for unplanned events a reflection one day after and another reflection a week later.

Considerations

Considerations are suggestions about what may be useful for the trainee to think about while undertaking a training activity. They should not be considered as a mandatory checklist. Trainees should not be expected to demonstrate or provide evidence for each of the considerations listed.

  • Reflect on the impact this will have on practice including:
    • IMP licensing
    • Role of the qualified person
    • Legislation of clinical trials
    • Range of ongoing trials
    • Processes for setting up clinical trial, ongoing management and close out

Relevant learning outcomes

# Outcome
# 1 Outcome

Explore the contribution of Radiopharmacy Services to patient care.

# 3 Outcome

Describe the working practices of Radiopharmacy Services.

# 4 Outcome

Examine the impact of innovation in Radiopharmacy Services.

# 6 Outcome

Compare and contrast the practice of Radiopharmacy Services with other areas of Pharmaceutical Sciences.